Loading chat...
NY A04141
Bill
Status
2/10/2023
Primary Sponsor
Phara Souffrant Forrest
Click for details
AI Summary
-
Eliminates all cost-sharing requirements (deductibles, copayments, coinsurance, and other out-of-pocket costs) for covered prescription insulin drugs under New York insurance law.
-
Applies to health insurance policies regulated under sections 3216, 3221, and 4303 of the insurance law, covering multiple insurance product types.
-
Replaces the previous $100 per 30-day supply cap on insulin costs with a complete prohibition on any cost-sharing for insulin medications.
-
Takes effect January 1, 2025 and applies to all policies issued, renewed, modified, altered, or amended on or after that date.
Legislative Description
Prohibits cost sharing for insulin; provides that an insured shall not be subject to a deductible, copayment, coinsurance or any other cost sharing requirement for the purchase of insulin.
Last Action
print number 4141a
1/25/2024